Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Gene Expression Changes on Extended Use of Dopamine Agonists in Restless Legs Syndrome (RLS)

NCT06726785 is registered in ClinicalTrials.gov with HBC Immunology Inc as lead sponsor.

NCT NCT06726785
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06726785 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Gene Expression Changes on Extended Use of Dopamine Agonists in Restless Legs Syndrome (RLS)
Lead sponsor
HBC Immunology Inc
Phase
Observational
Overall status
Recruiting
Start date
July 1, 2025
Completion date
February 27, 2026
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

restless leg syndrome (rls)